A Controlled Evaluation of the Australasian Peers for Progress Diabetes Program (PfP-DP) and its Transferability to Other Countries
This project aimed to evaluate the Australian peer-supported program for people with type 2 diabetes. Worldwide the "Peers for Progress" programs aim to address the global diabetes epidemic by extending the evidence base for peer support, establishing peer support as a core component of diabetes care and building a network of peer support programs around the world.
The Peers for Progress clinical trial has finished data collection and is in the analysis stage. The protocol paper has already been published.
Read more about the Australian Peers for Progress Diabetes program
Funding Body: Peers for Progress. A program of the American Academy of Family Physicians Foundation and is supported by the Eli Lilly and Company Foundation
Principal Investigator: Professor Brian Oldenburg (Monash University)
Investigators: Dr Pilvikki Absetz (National Institute of Health and Welfare (THL) Finland), Dr Ralph Audehm (Diabetes Australia - Victoria), Professor Rob Carter (Deakin University), Associate Professor Max de Courten (Monash University), Professor James Dunbar (GGT UDRH, Flinders University & Deakin University), Greg Johnson (Diabetes Australia - Victoria), Associate Professor Rory Wolfe & Professor Anuar Zaini (Monash University)